VelaLabs - #whatsnews
Find everything newsworthy related to VelaLabs, from Press Releases to new announcements, right here in this overview. Follow our social media to stay in touch with us.
Want to work with us? Write your request to us HERE and sign up to our Newsletter to stay up-to-date.
2024
June 2024 - VelaLabs got a freshly signed GMP certificate, staying up-to-date with the requirements needed for precise and GMP conform analytics
April 2024 - VelaLabs is "soon-to-be" a proud owner of a new Isolator from BLOCK®
2020 - 2023
July 2023 - Major changes are happening. Our new Managing Director Andreas Nechansky got a warm welcome from the Team and will continue to steer VelaLabs to success
February 2022 - VelaLabs turned fifteen years and it's time to revel in the festivities
May 2021 - VelaLabs becomes a proud member of BIOTECH AUSTRIA
October 2020 - VelaLabs in the cover story of Chemiereport.at
April 2020 - Kick-off for test runs at VelaLabs of the APN01 vaccine from Apeiron against the covid virus
February 2020 - Eurofins DiscoverX Grants Bioassay Certification to VelaLabs
January 2020 - VelaLabs restructures their management board and will kick off the new year with a trio of excellence on the top
2010 - 2019
July 2016 - VelaLabs celebrates its 10th anniversary with colleagues, friends and family and summarize their successes
June 2016 - Our CQO Klaus Hajszan talks about how to properly transfer qualified methods to a contract laboratory. Read about his insights and what steps are necessary for the transfer
June 2015 - VelaLabs uses it's many years of expertise and experience in the field of biosimilars to support medication development worldwide
April 2015 - Biosimilars, important economical alternatives to generics, grab attention worldwide and VelaLabs is well prepared for the incoming market shift
April 2014 - VelaLabs presents it's portfolio in the newest issue of the PharmaLab 2014
September 2013 - VelaLabs and Evercyte announce cooperation to provide immortalized cell lines for biosimilar characterization
April 2013 - VelaLabs introduces MSD (Mesoscale Discovery) and finalises first antibody detection project
February 2012 - Vela Laboratories and Anagnostics enter a strategic partnership to offer hybcell technology to biotech and pharma customers under GMP conditions
June 2011 - VelaLabs - CRO lab for Pharma and Biotech - and Protagen - GMP certified specialist in the characterization of protein drugs form a strategic alliance
August 2010 - In vitro Bio Assays - Human cell lines have become irreplaceable in modern biomedical research because they make it possible: to depict certain processes in the organism ex vivo. These Technology makes it possible to test a therapeutic product for effectiveness